Comment on 'Allograft Function and Muscle Mass Evolution After Kidney Transplantation' by Gaillard Et Al.: The Authors Reply
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Gaillard F, Bienaime F J Cachexia Sarcopenia Muscle. 2023; 14(3):1583-1584.
PMID: 36883476 PMC: 10235894. DOI: 10.1002/jcsm.13202.
References
1.
Elsayed M, Ferguson J, Stack A
. Association of Height with Elevated Mortality Risk in ESRD: Variation by Race and Gender. J Am Soc Nephrol. 2015; 27(2):580-93.
PMC: 4731104.
DOI: 10.1681/ASN.2014080821.
View
2.
Dienemann T, Ziolkowski S, Bender S, Goral S, Long J, Baker J
. Changes in Body Composition, Muscle Strength, and Fat Distribution Following Kidney Transplantation. Am J Kidney Dis. 2021; 78(6):816-825.
PMC: 8608755.
DOI: 10.1053/j.ajkd.2020.11.032.
View
3.
Morel A, Ouamri Y, Canoui-Poitrine F, Mule S, Champy C, Ingels A
. Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study. J Cachexia Sarcopenia Muscle. 2021; 13(1):386-396.
PMC: 8818595.
DOI: 10.1002/jcsm.12853.
View
4.
Zhang J, Shi W, Zou M, Zeng Q, Feng Y, Luo Z
. Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022; 14(1):17-29.
PMC: 9891953.
DOI: 10.1002/jcsm.13130.
View
5.
Gaillard F, Bienaime F
. Comment on 'Allograft function and muscle mass evolution after kidney transplantation' by Gaillard et al.: The authors reply. J Cachexia Sarcopenia Muscle. 2023; 14(3):1583-1584.
PMC: 10235894.
DOI: 10.1002/jcsm.13202.
View